Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
14.64
-1.11 (-7.05%)
At close: May 13, 2026, 4:00 PM EDT
14.65
+0.01 (0.07%)
After-hours: May 13, 2026, 6:16 PM EDT

Biodesix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
96.188.571.3249.0938.2154.51
Revenue Growth (YoY)
29.05%24.08%45.30%28.46%-29.89%19.64%
Cost of Revenue
17.2216.7215.5713.0114.1530.52
Gross Profit
78.8871.7855.7536.0824.0623.99
Selling, General & Admin
91.3687.5580.4567.3961.4650.52
Research & Development
12.42129.569.9913.112.79
Other Operating Expenses
0.040.110.240.040.081.62
Total Operating Expenses
103.8199.6590.2577.4274.6564.93
Operating Income
-24.94-27.87-34.5-41.34-50.59-40.94
Interest Expense
-8.01-7.72-8.26-9.54-8.07-4.51
Other Non-Operating Income (Expense)
0.990.32-0.18-1.27-6.792.29
Total Non-Operating Income (Expense)
-7.02-7.39-8.43-10.8-14.86-2.22
Pretax Income
-31.96-35.27-42.93-52.15-65.45-43.16
Net Income
-31.96-35.27-42.93-52.15-65.45-43.16
Net Income to Common
-31.96-35.27-42.93-52.15-65.45-43.16
Shares Outstanding (Basic)
886421
Shares Outstanding (Diluted)
886421
Shares Change (YoY)
15.02%16.71%57.59%95.03%53.86%465.63%
EPS (Basic)
-4.06-4.67-6.64-12.80-31.00-31.60
EPS (Diluted)
-4.06-4.67-6.64-12.80-31.00-31.60
Shares Outstanding
10.118.257.274.813.881.54
Free Cash Flow
-26.14-23.53-51.88-45.79-48.27-30.46
Free Cash Flow Per Share
-3.21-3.12-8.02-11.15-22.93-22.26
Gross Margin
82.08%81.11%78.17%73.50%62.96%44.01%
Operating Margin
-25.95%-31.50%-48.37%-84.22%-132.38%-75.11%
Profit Margin
-33.26%-39.85%-60.19%-106.23%-171.27%-79.18%
FCF Margin
-27.20%-26.59%-72.74%-93.28%-126.32%-55.89%
EBITDA
-19.31-22.2-28.73-38.01-44.74-37.76
EBITDA Margin
-20.10%-25.09%-40.27%-77.44%-117.09%-69.28%
EBIT
-24.94-27.87-34.5-41.34-50.59-40.94
EBIT Margin
-25.95%-31.50%-48.37%-84.22%-132.38%-75.11%
Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q